Therapeutic plasma exchange for worsening multiple sclerosis: Does it work?

Expert Review of Clinical Immunology

Volumn 5, Issue 5, 2009, Pages 491-493

  Khatri, Bhupendra O ^a  

^a ST LUKE S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISABILITY; EDITORIAL; HUMAN; MULTIPLE SCLEROSIS; PLASMAPHERESIS; PROGNOSIS; TREATMENT INDICATION; UNITED STATES;

EID: 77949803168     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.09.42     Document Type: Editorial

References (11)

1. Doidge N. Pain: the dark side of plasticity. In: The Brain that Changes Itself. Penguin Group, London, UK, 178 (2007).
2. Weiner HL, Dau PC, Khatri BO et al. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology 1143-1149 (1989).
3. Khatri BO, McQuillen MP, Harrington GJ et al. Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs. Neurology 312-319 (1985).
4. Khatri BO, McQuillen MP, Hoffmann RG et al. Plasma exchange in chronic progressive multiple sclerosis: a long term study. Neurology 409-414 (1991).
5. Rodriguez M, Karnes WE, Bartleson JD et al. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology 1100-1104 (1993).
6. Weinshenker B, OBrien P, Petterson T et al. A randomized trial of plasma exchange in acute CNS inflammatory demyelinating disease. Ann. Neurol. 46, 878-886 (1999).
7. Ellison G. Therapy aimed at slowing the rate of progression. In: Multiple Sclerosis. McDonald WI, Silbergerg D (Eds). Butterworth & Co. Publishers, London, UK, 158 (1986).
8. Khatri B, McQuillen M, Tarima S et al. Long-term improvement in the disability of worsening MS patients with plasma exchange: results of a 25 year follow-up study. Poster P05.154. Presented at: American Academy of Neurology 2009 Annual Meeting. Seattle, WA, USA, 25 April-2 May 2009.
9. Khatri BO. Vascular access via temporary radial artery catheterization for therapeutic plasma exchange. J. Clin. Apher. 18, 143 (2003).
10. Khatri BO, Koethe SM, McQuillen MP. Plasmapheresis with immunosuppressive drug therapy in progressive multiple sclerosis. Arch. Neurol. 41, 734-738 (1984).
11. Medenica RD, Mukerjee S, Huschart T et al. Interferon inhibitor factor predicting success of plasmapheresis in patients with multiple sclerosis. J. Clin. Apher. 9, 216-221 (1994).